BIANCA CALO: Open Payments
NPI 1184858540 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,432 in 16 payments from 3 companies in 2025. Trend: 2023 $10,140 · 2024 $6,913 · 2025 $4,432
Speaker / faculty: $4,035Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $2,234 |
| ABBVIE INC. | 8 | $2,178 |
| Madrigal Pharmaceuticals | 1 | $20 |
Products named: MAVYRET, Vemlidy, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
